Cargando…
On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?
Metastasis is the leading cause of death for cancer patients. During cancer progression, the initial detachment of cells from the primary tumor and the later colonization of a secondary organ are characterized as limiting steps for metastasis. Epithelial-mesenchymal transition (EMT) and mesenchymal-...
Autores principales: | Teixeira, Adilson Fonseca, ten Dijke, Peter, Zhu, Hong-Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360684/ https://www.ncbi.nlm.nih.gov/pubmed/32733895 http://dx.doi.org/10.3389/fcell.2020.00605 |
Ejemplares similares
-
Editorial: TGF-β and BMP signaling in cancer
por: Yan, Xiaohua, et al.
Publicado: (2022) -
TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering
por: Ma, Jin, et al.
Publicado: (2020) -
TGF-β-Induced Endothelial to Mesenchymal Transition Is Determined by a Balance Between SNAIL and ID Factors
por: Ma, Jin, et al.
Publicado: (2021) -
The Roles of TGF-β Signaling in Cerebrovascular Diseases
por: Zhang, Yizhe, et al.
Publicado: (2020) -
Diverse Role of TGF-β in Kidney Disease
por: Gu, Yue-Yu, et al.
Publicado: (2020)